Item 1. | Security and Issuer. |
This statement relates to shares of common stock, par value $0.01 per share (“Common Stock”), of Repro Med Systems, Inc., a New York corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 24 Carpenter Road, Chester, NY 10918.
Horton Capital Partners Fund, LP, a Delaware limited partnership (“HCPF”), Horton Capital Partners LLC, a Delaware limited liability company (“HCP��), Horton Capital Management, LLC, a Delaware limited liability company (“HCM”), and Joseph M. Manko, Jr. (“Mr. Manko”) filed Schedule 13D with the Securities and Exchange Commission (the “SEC”) on May 23, 2017, as amended by Amendments Nos. 1 - 4 filed on December 4, 2017, December 21, 2017, March 16, 2018 and September 20, 2018 (“Schedule 13D”), to report their beneficial ownership of the shares of Common Stock of the Issuer. This Amendment No. 5 (“Amendment No. 5”) is filed with the SEC to amend and supplement Schedule 13D.
Item 2. | Identity and Background. |
(a) This statement is filed by HCPF, Horton Freedom, L.P., a Delaware limited partnership (“Horton Freedom”), HCP, HCM, and Mr. Manko (Mr. Manko together with HCPF, Horton Freedom, HCP and HCM, the “Reporting Persons” and each a “Reporting Person”), with respect to shares of Common Stock of the Issuer.
(b) The address of the principal office of each Reporting Person is 1717 Arch Street, Suite 3920, Philadelphia, PA 19103. The managing member of HCP and HCM is Mr. Joseph M. Manko, Jr.
(c) The principal business of HCPF, Horton Freedom and HCP is purchasing, holding and selling securities for investment purposes. The principal business of HCM is serving as the investment manager of HCPF and Horton Freedom. HCP is the general partner of HCPF and Horton Freedom. The principal occupation of Mr. Manko is serving as the managing member of HCM and HCP.
(d) No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) Mr. Manko is a citizen of the United States of America.
Item 3. | Source and Amounts of Funds or other Consideration. |
The shares of Common Stock acquired by the Reporting Persons as set forth in this Amendment No. 5 (the “Shares”) were purchased with the working capital of HCPF, Horton Freedom or HCM, as applicable (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). On September 28, 2018, 1,894 shares of Common Stock were issued to HCPF in consideration for Mr. Manko’s services as a director of the Issuer (“Director Shares”)